Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors.

Eriksson B, Annibale B, Bajetta E, Mitry E, Pavel M, Platania M, Salazar R, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society.

Neuroendocrinology. 2009;90(2):214-9. doi: 10.1159/000225950. Epub 2009 Aug 28. No abstract available.

PMID:
19713713
2.

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biotherapy.

Oberg K, Ferone D, Kaltsas G, Knigge UP, Taal B, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society.

Neuroendocrinology. 2009;90(2):209-13. doi: 10.1159/000183751. Epub 2009 Aug 28. No abstract available.

PMID:
19077379
3.

[Chemotherapy of digestive neuroendocrine tumors].

Rougier P, Toma C, Fabri MC, Ducreux M.

Ann Gastroenterol Hepatol (Paris). 1995 Mar-Apr;31(2):117-20. Review. French. No abstract available.

PMID:
7618833
4.

[Conservative treatment undifferentiated neuroendocrine tumors of the anal canal: two cases].

Lepère C, Rakotomalala S, Maindrault-Goebel F, Mitry E, Vaillant JN, Julie C, Otmezguine Y, Rougier P.

Gastroenterol Clin Biol. 2007 Apr;31(4):445-7. French.

5.

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs.

Kwekkeboom DJ, Krenning EP, Lebtahi R, Komminoth P, Kos-Kudła B, de Herder WW, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society.

Neuroendocrinology. 2009;90(2):220-6. doi: 10.1159/000225951. Epub 2009 Aug 28.

PMID:
19713714
6.

Effect of interferon and 5-fluorouracil on serum VEGF levels in neuroendocrine tumours.

Van Der Horst-Schrivers AN, Slot MH, Willemse PH, Kema IP, De Vries EG, Wymenga AN.

Acta Oncol. 2008;47(1):153-5. No abstract available.

PMID:
17851877
7.

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors.

Akerström G, Falconi M, Kianmanesh R, Ruszniewski P, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society.

Neuroendocrinology. 2009;90(2):203-8. doi: 10.1159/000225949. Epub 2009 Aug 28. No abstract available.

PMID:
19713712
8.

Neuroendocrine tumors (NETs).

Bajetta E, Procopio G, Guadalupi V, Del Vecchio M.

Clin Ther. 2009 Sep;31(9):2060-1. doi: 10.1016/j.clinthera.2009.09.007. No abstract available.

PMID:
19843495
9.

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation.

Arnold R, Chen YJ, Costa F, Falconi M, Gross D, Grossman AB, Hyrdel R, Kos-Kudła B, Salazar R, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society.

Neuroendocrinology. 2009;90(2):227-33. doi: 10.1159/000225952. Epub 2009 Aug 28. No abstract available.

PMID:
19713715
10.

Medical oncology considerations in patients with metastatic neuroendocrine carcinomas.

Kvols L.

Semin Oncol. 1994 Oct;21(5 Suppl 13):56-60. No abstract available.

PMID:
7992083
11.

Bevacizumab and subtype-adapted chemotherapy backbone in neuroendocrine tumors.

Hadoux J, Ducreux M.

J Clin Oncol. 2013 Mar 1;31(7):976-7. doi: 10.1200/JCO.2012.47.0351. Epub 2013 Jan 28. No abstract available.

PMID:
23358990
12.

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers.

O'Toole D, Grossman A, Gross D, Delle Fave G, Barkmanova J, O'Connor J, Pape UF, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society.

Neuroendocrinology. 2009;90(2):194-202. doi: 10.1159/000225948. Epub 2009 Aug 28. No abstract available.

PMID:
19713711
13.

ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine Tumors.

Plöckinger U, Wiedenmann B, de Herder WW.

Neuroendocrinology. 2009;90(2):159-61. doi: 10.1159/000225945. Epub 2009 Aug 28. No abstract available.

PMID:
19713708
14.

Treatment of gastroenteropancreatic neuroendocrine tumors.

Plöckinger U, Wiedenmann B.

Virchows Arch. 2007 Aug;451 Suppl 1:S71-80. Epub 2007 Aug 8. Review.

PMID:
17684765
15.

Bevacizumab plus temozolomide: a novel treatment option for advanced neuroendocrine tumors?

Koumarianou A, Kaltsas G.

J Clin Oncol. 2013 Mar 1;31(7):975-6. doi: 10.1200/JCO.2012.45.7523. Epub 2013 Jan 28. No abstract available.

PMID:
23358970
16.

Neuroendocrine tumors: novel approaches in the age of targeted therapy.

Phan AT, Yao JC.

Oncology (Williston Park). 2008 Dec;22(14):1617-23; discussion 1623-4, 1629.

PMID:
19198220
17.

Neuroendocrine tumor of the rectum.

Suyama K, Hayashi N, Shigaki H, Sato N, Hirashima K, Nagai Y, Hiyoshi Y, Sakamoto Y, Yoshida N, Toyama E, Watanabe M, Baba H.

Am J Surg. 2009 Sep;198(3):e39-41. doi: 10.1016/j.amjsurg.2009.01.031.

PMID:
19716878
18.
19.

Neuroendocrine tumors. Biotherapy.

Plöckinger U, Wiedenmann B.

Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):145-62. Review.

PMID:
17382270
20.

[Treatment of neuroendocrine tumors of the digestive tract].

Wada I, Shimizu N, Seto Y.

Gan To Kagaku Ryoho. 2009 Oct;36(10):1606-10. Japanese.

PMID:
19838017

Supplemental Content

Support Center